Education
About Us
Working with TipRanks
Follow Us
Azitra Inc (AZTR)
:AZTR
AZTR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.23 - $12.00
Previous CloseN/A
Volume201.32K
Average Volume (3M)709.76K
Market Cap
N/A
Enterprise Value$63.94M
Total Cash (Recent Filing)$3.21B
Total Debt (Recent Filing)$473.71M
Price to Earnings (P/E)―
Beta1.55
Next Earnings
Aug 18, 2025EPS Estimate
-0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding17,226,355
10 Day Avg. Volume540,696
30 Day Avg. Volume709,758
Financial Highlights & Ratios
PEG Ratio-0.29
Price to Book (P/B)-1.65
Price to Sales (P/S)0.00
P/FCF Ratio-7.02
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.12
Enterprise Value/Gross Profit8.40
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$3.00Price Target Upside1053.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Azitra Inc News
PremiumCompany Announcements
Azitra Inc Announces Positive Phase 1b Trial Results
Bulls Say, Bears Say
Bulls Say
Clinical TrialsFocus remains on lead program ATR-12 in Netherton syndrome, which dosed the first patient in its P1b study, with initial data expected soon.
Regulatory ApprovalsATR-04 has fast track designation, indicating a streamlined development process to potentially bring the therapy to market sooner.
Bears Say
Financial PerformanceFactoring in dilution associated with the two recent financings lowers the 12-month price target to $2.00, from $3.00.
Options Prices
Currently, No data available
---
Ownership Overview
5.80% Insiders
0.20%
Mutual Funds
0.39% Other Institutional Investors
99.41% Public Companies and Individual Investors
AZTR FAQ
What was Azitra Inc’s price range in the past 12 months?
Azitra Inc lowest stock price was $0.23 and its highest was $12.00 in the past 12 months.
What is Azitra Inc’s market cap?
Currently, no data Available
When is Azitra Inc’s upcoming earnings report date?
Azitra Inc’s upcoming earnings report date is Aug 18, 2025 which is in 61 days.
How were Azitra Inc’s earnings last quarter?
Azitra Inc released its earnings results on May 13, 2025. The company reported -$0.23 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.23.
Is Azitra Inc overvalued?
According to Wall Street analysts Azitra Inc’s price is currently Undervalued.
Does Azitra Inc pay dividends?
Azitra Inc does not currently pay dividends.
What is Azitra Inc’s EPS estimate?
Azitra Inc’s EPS estimate is -0.21.
How many shares outstanding does Azitra Inc have?
Azitra Inc has 17,226,355 shares outstanding.
What happened to Azitra Inc’s price movement after its last earnings report?
Azitra Inc reported an EPS of -$0.23 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Azitra Inc?
Currently, no hedge funds are holding shares in AZTR
Company Description
Azitra Inc
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
Technical Analysis
Biodexa Pharmaceuticals
―
Salarius Pharmaceuticals
―
Processa Pharmaceuticals
―
GRI Bio
―
Protagenic Therapeutics
―